Balsalazide sodium - Inflammatory bowel disease
You are here : Home > Formulary Search > Balsalazide sodium - Inflammatory bowel disease
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Non Formulary
Formulations :
- Not Specified
Formulary Status :
Associated Icons :
Restrictions / Comments :
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Balsalazide sodium
Indication :
Inflammatory bowel disease
Group Name :
Keywords :
Ulcerative colitis, UC, IBD, Chronic Bowel Disorders, Inflammatory Bowel Disease
Brand Names Include :
Colazide
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Other Indications
Below are listed other indications that Balsalazide sodium is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Inflammatory bowel disease.
Committee Recommendations (1)
13 Jun 16 -
Not Set
This drug / device has not yet been evaluated by NICE or the Surrey and Sussex Prescribing Clinical Network (PCN). As such, advice regarding safety, effectiveness (including cost-effectiveness) and its place in therapy is yet to be determined. It is recommended that clinicians contact their medicines management team for further information and advice before prescribing this drug / device.
This drug is currently not on the PCN workplan. The PCN will consider recommending prescribing of this treatment upon submission of a formal request with its associated evidence. Please contact your local CCG Medicines Management team formulary pharmacist or chief pharmacist at your acute trust, if you wish to make a submission.
This drug is currently not on the PCN workplan. The PCN will consider recommending prescribing of this treatment upon submission of a formal request with its associated evidence. Please contact your local CCG Medicines Management team formulary pharmacist or chief pharmacist at your acute trust, if you wish to make a submission.